NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event

Rhea-AI Summary

NeuroOne Medical Technologies (Nasdaq: NMTC), a medical technology company specializing in neurological disorder treatments, has announced its participation in the upcoming Virtual Investor Summit Microcap Event on November 21, 2024. The company will deliver a presentation from 1:30 PM to 2:00 PM ET and will be available for one-on-one meetings throughout the day.

The event will showcase 40 micro-cap companies with catalysts and/or strong market performance. Interested qualified investors can register for complimentary access to participate in live Q&A sessions and engage with leading MicroCap investors.

News Market Reaction – NMTC

-2.81%

-2.81% Session move

In the trading session that priced this news, NMTC declined 2.81%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

EDEN PRAIRIE, MN / ACCESSWIRE / November 13, 2024 / NeuroOne Medical Technologies Corporation (Nasdaq:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it will be participating in the Virtual Investor Summit Microcap Event. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation.

Event: Q4 Investor Summit
Date: Thursday, November 21, 2024
Presentation Time: 1:30pm - 2:00pm ET
Location: https://www.webcaster4.com/Webcast/Page/3075/51590

• The theme is 40 micro-cap companies with a catalyst and/or strong performance in the current market.

• Take a deep dive with the best Investors in MicroCap

• Live Q & A

• Complimentary to Qualified Investors. Please REGISTER HERE.

About the Investor Summit

The Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. Founded in 2015.

About NeuroOne
NeuroOne Medical Technologies Corporation is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit www.nmtc1.com.

Contact:
Fred Rockwell
fred@investorsummitgroup.com
Investor Summit Group

NMTC IR Contact
Quinn Callanan, CFA or Brian Prenoveau, CFA
MZ Group - MZ North America
NMTC@mzgroup.us
(949) 694-9594

SOURCE: NeuroOne Medical Technologies Corporation

View the original press release on accesswire.com

FAQ

When is NeuroOne Medical Technologies (NMTC) presenting at the Virtual Investor Summit?

NeuroOne Medical Technologies (NMTC) will present on Thursday, November 21, 2024, from 1:30 PM to 2:00 PM ET.

What type of companies are featured at the November 2024 Virtual Investor Summit?

The event features 40 micro-cap companies that demonstrate strong market performance or have significant catalysts.

Is there a cost to attend NMTC's presentation at the Virtual Investor Summit?

The event is complimentary for qualified investors who register through the provided link.

What opportunities are available for investors to interact with NMTC at the Virtual Investor Summit?

Investors can attend the company's presentation, participate in live Q&A sessions, and schedule one-on-one meetings throughout the day.